011312 NIACINAMIDE 4% / TAZAROTENE 0.05%- 011312 niacinamide 4% / tazarotene 0.05% cream 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

011312 NIACINAMIDE 4% / TAZAROTENE 0.05%

Directions for use

e

Sincerus Florida, LLC adverse reactions

s

Active, Inactive

a


NDC 72934-2208-2 011312 NIACINAMIDE 4% / TAZAROTENE 0.05% cream 30 gm

d

011312 NIACINAMIDE 4% / TAZAROTENE 0.05% 
011312 niacinamide 4% / tazarotene 0.05% cream
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:72934-2208
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TAZAROTENE (UNII: 81BDR9Y8PS) (TAZAROTENE - UNII:81BDR9Y8PS) TAZAROTENE0.05 g  in 100 g
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE4 g  in 100 g
Product Characteristics
ColorwhiteScore    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72934-2208-230 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product07/02/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other07/02/2020
Labeler - Sincerus Florida, LLC (080105003)
Establishment
NameAddressID/FEIBusiness Operations
Sincerus Florida, LLC080105003manufacture(72934-2208)

Revised: 7/2020
Document Id: a97a190f-1f99-1fb0-e053-2a95a90a6850
Set id: a97a190f-1f98-1fb0-e053-2a95a90a6850
Version: 1
Effective Time: 20200702
 
Sincerus Florida, LLC